For decades, targeting RAS mutations in pancreatic cancer has been one of oncology's greatest challenges. Dr. Rachael Safyan discusses how new, targeted therapies are finally shifting the treatment landscape and offering patients a chance to live longer, better lives. #WebMD #PancreaticCancer #CancerTreatment #KRAS #Oncology #CancerResearch #MedicalAdvance